Benign Prostatic Hyperplasia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Efficacy and Safety of DKF-313 in Patients With Benign Prostatic Hyperplasia
Condition: Benign Prostatic Hyperplasia Interventions: Drug: DKF-313; Drug: Dutasteride; Drug: Tadalafil; Drug: DKF-313 placebo; Drug: Dutasteride placebo; Drug: Tadalafil placebo Sponsor: Dongkook Pharmaceutical Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 1, 2021 Category: Research Source Type: clinical trials
